Jiangsu Nanfang Medical (603880) — Capital Reinvestment Ratio
Jiangsu Nanfang Medical (603880) has a Capital Reinvestment Ratio of 0.18x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥12.53 Million) in capital expenditures (CN¥2.25 Million). See 603880 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Nanfang Medical Capital Reinvestment Ratio (2012–2025)
This chart tracks Jiangsu Nanfang Medical's Capital Reinvestment Ratio across 13 annual periods. Check 603880 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Jiangsu Nanfang Medical (2012–2025)
Year-by-year Capital Reinvestment Ratio for Jiangsu Nanfang Medical from 2012 to 2025. For live market cap and broader valuation context, see Jiangsu Nanfang Medical market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥47.73 Million | CN¥13.20 Million | ▼ -46.0% |
| 2024 | 0.51x | CN¥63.32 Million | CN¥32.41 Million | ▼ -88.0% |
| 2023 | 4.27x | CN¥15.51 Million | CN¥66.16 Million | ▼ -8.7% |
| 2022 | 4.67x | CN¥31.28 Million | CN¥146.16 Million | ▲ +484.2% |
| 2020 | 0.80x | CN¥154.12 Million | CN¥123.29 Million | ▼ -53.2% |
| 2019 | 1.71x | CN¥32.99 Million | CN¥56.36 Million | ▲ +15.9% |
| 2018 | 1.47x | CN¥52.75 Million | CN¥77.76 Million | ▲ +133.1% |
| 2017 | 0.63x | CN¥49.24 Million | CN¥31.14 Million | ▲ +16.3% |
| 2016 | 0.54x | CN¥99.35 Million | CN¥54.03 Million | ▲ +11.3% |
| 2015 | 0.49x | CN¥90.66 Million | CN¥44.30 Million | ▲ +417.8% |
| 2014 | 0.09x | CN¥73.52 Million | CN¥6.94 Million | ▼ -93.4% |
| 2013 | 1.43x | CN¥20.14 Million | CN¥28.81 Million | ▲ +409.4% |
| 2012 | 0.28x | CN¥76.07 Million | CN¥21.36 Million | — |